# Document 15: Comprehensive Pathologies Summary

## Introduction

This document provides a comprehensive summary of all pathologies, disorders, syndromes, and medical conditions discussed throughout the Human Growth and Development textbook. Organized alphabetically for easy reference, each entry includes definition, causes, symptoms, prevalence, diagnostic criteria when applicable, and treatment approaches. This summary serves as a quick reference guide for understanding the various medical and psychological conditions that can affect development across the lifespan.

## Pathologies Organized Alphabetically

### Acquired Immunodeficiency Syndrome (AIDS)

**Definition:** Advanced stage of HIV infection where the immune system is severely compromised.

**Cause:** Human Immunodeficiency Virus (HIV) that attacks and destroys CD4 T cells, progressively weakening the immune system.

**Transmission:** Sexual contact, blood exposure, sharing needles, mother-to-child transmission during pregnancy/childbirth/breastfeeding.

**Symptoms:** Opportunistic infections, certain cancers, severe weight loss, chronic diarrhea, neurological complications, weakened immune system.

**Prevalence:** Nearly 25 percent of people living with HIV-AIDS in the United States are 50 or older.

**Treatment:** Antiretroviral therapy (ART) can suppress viral load to undetectable levels, preventing AIDS and transmission. Without treatment, HIV progressively destroys immune function.

### Advanced Sleep Phase Syndrome

**Definition:** Shift in sleep-wake cycle where individuals go to sleep earlier and wake earlier than typical.

**Cause:** Changes in circadian rhythms associated with aging.

**Symptoms:** Early evening sleepiness, early morning awakening, difficulty staying awake in evening, waking earlier than desired.

**Prevalence:** Common in older adults.

**Treatment:** Light therapy, chronotherapy, maintaining consistent sleep schedule.

### Alcohol Use Disorder

**Definition:** Problematic pattern of alcohol use leading to clinically significant impairment or distress.

**Causes:** Genetic vulnerability (40-60%), environmental factors, psychological factors, early exposure to alcohol.

**Symptoms:** Inability to control drinking, continued use despite negative consequences, tolerance, withdrawal symptoms, spending excessive time obtaining/using alcohol.

**Prevalence:** Approximately 1 in 5 college students meet criteria for Alcohol Use Disorder.

**Consequences:** Liver disease (fatty liver, hepatitis, cirrhosis), cardiovascular problems, cognitive impairment, increased cancer risk, mental health problems.

**Treatment:** Detoxification, medication-assisted treatment (disulfiram, acamprosate, naltrexone), cognitive-behavioral therapy, 12-step programs, residential treatment, outpatient programs.

### Alpha-1 Antitrypsin (AAT) Deficiency

**Definition:** Recessive genetic condition where abnormal AAT protein cannot leave the liver.

**Cause:** Genetic mutation affecting AAT protein production.

**Symptoms:** Increased risk for lung disease (especially when exposed to environmental irritants), potential liver disease.

**Prevalence:** Varies by population; some individuals with AAT deficiency are not affected.

**Treatment:** Avoidance of environmental irritants (smoking, pollution), monitoring lung and liver function, symptomatic treatment.

### Alzheimer's Disease

**Definition:** Progressive neurodegenerative disease characterized by memory loss, cognitive decline, and behavioral changes.

**Causes:** 
- Age (greatest risk factor)
- Genetic factors (familial Alzheimer's involves specific genes)
- Environmental factors (traumatic brain injury, obesity, hypertension, high cholesterol, diabetes)
- Beta-amyloid plaques and tau tangles that interfere with neuron functioning

**Symptoms:**
- Early stages: Subtle personality changes, memory loss different from normal aging
- Middle stages: Confusion, difficulty with change, deterioration in language, problem-solving, personality
- Late stages: Loss of physical coordination, inability to complete everyday tasks including self-care, loss of ability to respond to environment and control movement

**Prevalence:** 5.4 million Americans diagnosed in 2016; approximately one in nine aged 65 and over. Five percent of cases occur before age 65 (early-onset).

**Risk Factors:** Age, family history, genetics (deterministic genes for early-onset), traumatic brain injury, cardiovascular risk factors.

**Pathophysiology:**
- Beta-amyloid plaques block cell communication and trigger inflammatory response
- Tau tangles disrupt brain's transport system
- Neuron death leads to brain shrinkage
- Hippocampus typically damaged first (explaining early memory loss)

**Treatment:** No cure. Medications may temporarily improve or stabilize symptoms. Comprehensive lifestyle interventions (healthy diet, physical activity, cognitive engagement, social activity, not smoking, light to moderate alcohol) can reduce risk by 60%.

### Anorexia Nervosa

**Definition:** Eating disorder characterized by restriction of energy intake, intense fear of weight gain, and body image disturbance.

**DSM-5 Criteria:**
- Restriction of energy intake leading to significantly low body weight
- Intense fear of gaining weight or persistent behavior interfering with weight gain
- Disturbance in body image

**Subtypes:**
- Restricting type: Weight loss through dieting, fasting, excessive exercise
- Binge-eating/purging type: Regular binge eating or purging behaviors

**Risk Factors:** 
- Genetic vulnerability
- Perfectionism, low self-esteem, poor body image
- Cultural pressures emphasizing thinness
- Puberty (particularly early-maturing girls who experience teasing)
- Troubled family relationships, history of abuse

**Demographics:** More common among non-Hispanic Whites; onset typically in adolescence or early adulthood; disproportionately affects females.

**Medical Complications:**
- Abnormally slow heart rate and low blood pressure
- Reduction in bone density (osteoporosis)
- Muscle loss and weakness
- Severe dehydration
- Hair loss; growth of fine body hair (lanugo)
- Kidney failure
- Amenorrhea in females
- Brain damage
- Multi-organ failure
- Highest mortality rate of any psychiatric disorder

**Treatment:**
- Medical stabilization
- Nutritional counseling and weight restoration
- Psychotherapy (CBT, Family-Based Therapy particularly effective for adolescents)
- Medications (SSRIs for co-occurring conditions)
- Hospitalization when medically necessary

### Asthma

**Definition:** Chronic lung disease causing airways to become inflamed and narrowed.

**Prevalence:** Approximately 6 million children in the United States; 6.9% of adults aged 65+.

**Triggers:** Allergens, respiratory infections, exercise, cold air, air pollution, stress.

**Symptoms:** Wheezing, shortness of breath, chest tightness, coughing, difficulty breathing.

**Treatment:**
- Avoiding triggers
- Controller medications (inhaled corticosteroids)
- Rescue inhalers for acute symptoms
- Asthma action plans
- Regular medical follow-up

**Impact:** Can limit physical activity, cause school absences, disrupt sleep. Most children with proper management can lead normal, active lives.

### Atherosclerosis

**Definition:** Buildup of fats, cholesterol, and other substances in artery walls, restricting blood flow.

**Cause:** Not part of normal aging; caused by disease processes.

**Risk Factors:** High cholesterol, high blood pressure, smoking, diabetes, obesity, physical inactivity, unhealthy diet.

**Symptoms:** May be asymptomatic until advanced; can lead to heart attack, stroke, peripheral artery disease.

**Prevalence:** Leading cause of death in late adulthood.

**Treatment:** Lifestyle modifications (diet, exercise), medications (statins, blood pressure medications, antiplatelet agents), surgical interventions when necessary.

### Attention-Deficit/Hyperactivity Disorder (ADHD)

**Definition:** Neurodevelopmental disorder characterized by persistent patterns of inattention and/or hyperactivity-impulsivity.

**Symptoms:**
- Inattention: Difficulty sustaining attention, frequent careless mistakes, difficulty organizing tasks, forgetfulness
- Hyperactivity: Fidgeting, inability to stay seated, excessive talking
- Impulsivity: Difficulty waiting turn, interrupting others, acting without thinking

**Prevalence:** Common childhood disorder; can persist into adulthood.

**Treatment:** Stimulant medications, behavioral therapy, parent training, school accommodations, organizational skills training.

### Binge-Eating Disorder

**Definition:** Eating disorder involving recurrent binge eating without compensatory behaviors.

**DSM-5 Criteria:**
- Recurrent episodes of binge eating (eating large amounts with sense of loss of control)
- Marked distress regarding binge eating
- Occurs at least weekly for three months
- Not associated with compensatory behaviors (unlike bulimia nervosa)

**Risk Factors:** Similar to other eating disorders; genetic, psychological, and sociocultural factors.

**Medical Complications:**
- High blood pressure
- High cholesterol
- Heart disease
- Type 2 diabetes
- Gallbladder disease
- Certain cancers
- Sleep apnea
- Osteoarthritis

**Treatment:**
- Cognitive-Behavioral Therapy (strong evidence base)
- Interpersonal Therapy
- Medications (SSRIs, lisdexamfetamine)
- Nutritional counseling
- Treatment of co-occurring obesity when present

### Bipolar Disorder

**Definition:** Mental illness involving extreme mood swings including manic and depressive episodes.

**Types:**
- **Bipolar I:** At least one manic episode (may include depressive episodes)
- **Bipolar II:** At least one hypomanic episode and one major depressive episode (no full manic episodes)
- **Cyclothymic Disorder:** Numerous periods of hypomanic and depressive symptoms lasting at least two years

**Manic Episode Symptoms:**
- Elevated, expansive, or irritable mood
- Increased energy and activity
- Decreased need for sleep
- Grandiosity
- Racing thoughts, rapid speech
- Impulsivity and risky behaviors
- Distractibility

**Depressive Episode Symptoms:** Similar to major depressive disorder.

**Treatment:**
- Mood stabilizers (lithium, valproic acid, carbamazepine)
- Antipsychotics (particularly for acute mania)
- Psychotherapy (CBT, family-focused therapy, interpersonal and social rhythm therapy)
- Lifestyle regularity (consistent sleep-wake cycles)
- Avoiding substances

### Bulimia Nervosa

**Definition:** Eating disorder characterized by recurrent binge eating followed by inappropriate compensatory behaviors.

**DSM-5 Criteria:**
- Recurrent episodes of binge eating
- Recurrent inappropriate compensatory behaviors (self-induced vomiting, laxative/diuretic misuse, fasting, excessive exercise)
- Self-evaluation unduly influenced by body shape and weight
- Occurs at least weekly for three months
- Does not occur exclusively during anorexia nervosa

**Risk Factors:** Genetic, psychological (perfectionism, impulsivity), sociocultural (cultural emphasis on thinness), developmental (puberty), interpersonal factors.

**Medical Complications:**
- Electrolyte imbalances affecting heart and organs
- Inflammation and potential rupture of esophagus
- Tooth decay from stomach acids
- Chronic bowel problems from laxative abuse
- Gastric rupture
- Swollen salivary glands

**Treatment:**
- Cognitive-Behavioral Therapy (strong evidence base)
- Nutritional counseling
- Medications (SSRIs particularly fluoxetine)
- Stopping compensatory behaviors
- Medical monitoring

### Cancer (General)

**Definition:** Group of diseases characterized by abnormal cell growth with potential to invade or spread to other parts of the body.

**Age and Cancer:**
- Advancing age is significant risk factor
- Persons over 65 account for 60% of newly diagnosed cancer and 70% of cancer deaths
- More than 70% of mortality for many cancers occurs in those 65+

**Common Cancers in Late Adulthood:** Prostate, bladder, colon, uterus, pancreas, stomach, rectum, lung.

**Complications in Older Adults:**
- Multiple comorbid conditions
- Decline in organ systems affecting medication tolerance
- Chemotherapy can compromise cognitive function, may exacerbate dementia
- Depression associated with decreased survival rates

**Treatment Considerations:**
- Frail individuals may not be candidates for toxic chemotherapy
- Screening for depression recommended
- Risk of malnutrition higher
- Diminished sensory function increases vulnerability

### Cataracts

**Definition:** Clouding of the eye's lens reducing clarity and causing discoloration.

**Cause:** Protein in eye clumps together, reducing lens clarity. Lens tints yellow/brown, interfering with color distinction.

**Prevalence:** More people have problems after age 60; by age 75, 70% of adults have cataract problems.

**Risk Factors:** Age, diabetes, high blood pressure, obesity, smoking, prolonged UV exposure, previous eye trauma, long-term steroid use, family history.

**Symptoms:** Blurred vision, difficulty seeing in low light, sensitivity to glare, faded colors, difficulty distinguishing dark colors (black, brown, blue, purple).

**Treatment:** Surgical removal and replacement of lens with synthetic lens (only cure).

### Childhood Cancer

**Common Types:**
- Leukemia (most common)
- Brain and central nervous system tumors
- Neuroblastoma
- Wilms tumor
- Lymphomas
- Bone cancers

**Treatment Effects:**
- Improved survival rates
- Long-term effects: Cognitive impacts, growth/development delays, organ damage, secondary cancers, fertility problems, psychological effects

**Psychosocial Impact:** Affects entire family; emotional distress, treatment burden, educational disruptions, financial strain, social isolation, uncertainty about future.

### Chlamydia

**Definition:** Bacterial sexually transmitted infection.

**Prevalence:** Most commonly reported STI in the United States; 1.4 million cases in 2014.

**Symptoms:** Often asymptomatic, particularly in women. When present: abnormal discharge, burning during urination, pelvic pain.

**Complications:** Pelvic inflammatory disease (PID), infertility, ectopic pregnancy if untreated.

**Treatment:** Curable with antibiotics.

### Chronic Bronchitis

**Definition:** Inflammation of bronchial tubes causing persistent cough with mucus.

**Prevalence:** 5.0% of adults aged 65+.

**Cause:** Usually from smoking; can be part of COPD.

**Symptoms:** Persistent cough producing mucus, wheezing, shortness of breath, chest discomfort.

**Treatment:** Smoking cessation, bronchodilators, corticosteroids, pulmonary rehabilitation.

### Chronic Obstructive Pulmonary Disease (COPD)

**Definition:** Progressive lung disease making breathing difficult, includes emphysema and chronic bronchitis.

**Causes:** Primary cause is cigarette smoking; other tobacco smoking; genetics (AAT deficiency).

**Symptoms:**
- Shortness of breath
- Chronic cough
- Wheezing
- Chest tightness
- Frequent respiratory infections

**Diagnosis:** Often not diagnosed until midlife or late adulthood.

**Treatment:** No cure; treatments aim to slow progression. Includes bronchodilators, corticosteroids, oxygen therapy, pulmonary rehabilitation, smoking cessation.

### Complicated Grief

**Definition:** Atypical grief reactions lasting six months or longer with severe symptoms.

**Symptoms:**
- Disbelief about death
- Preoccupation with deceased
- Distressful memories
- Inability to move forward
- Yearning for deceased
- Symptoms mirror major depressive disorder

**Risk Factors:** Traumatic forms of bereavement (unexpected, multiple, violent deaths, murders, suicides).

**Treatment:** Grief counseling, psychotherapy, possible medication for co-occurring depression.

### Congenital Adrenal Hyperplasia

**Definition:** Condition involving abnormal prenatal androgen exposure.

**Effect on Development:** One-third of females exposed identify as bisexual or lesbian in adulthood.

**Symptoms:** Vary depending on severity; can include ambiguous genitalia, early puberty, fertility issues.

**Treatment:** Hormone replacement therapy, surgical intervention when indicated.

### Dementia (See Neurocognitive Disorders)

### Depression (Major Depressive Disorder)

**Definition:** Mental health disorder characterized by persistent sadness, loss of interest, and additional symptoms affecting functioning.

**Symptoms (DSM-5 requires 5+ for at least 2 weeks):**
- Persistent sadness or depressed mood
- Loss of interest or pleasure (anhedonia)
- Changes in appetite or weight
- Sleep disturbances (insomnia or hypersomnia)
- Psychomotor agitation or retardation
- Fatigue or loss of energy
- Feelings of worthlessness or excessive guilt
- Difficulty concentrating or making decisions
- Recurrent thoughts of death or suicide

**Prevalence:** One of most common mental health disorders; increases during adolescence, particularly among females.

**Risk Factors:**
- Biological: Genetics, neurotransmitter imbalances, hormonal changes
- Psychological: Negative thinking patterns, trauma history, low self-esteem
- Social: Relationship problems, social isolation, discrimination, adverse life events
- Environmental: Chronic stress, poverty, lack of social support

**Treatment:**
- Psychotherapy (CBT, interpersonal therapy, behavioral activation)
- Medications (SSRIs, SNRIs, TCAs, MAOIs, atypical antidepressants)
- Combined treatment (medication + psychotherapy often most effective)
- Other interventions: Exercise, light therapy (seasonal affective disorder), ECT (severe cases), TMS

### Diabetes (Type 1)

**Definition:** Autoimmune condition where pancreas produces little or no insulin.

**Onset:** Typically childhood or adolescence, though can occur at any age.

**Management:**
- Insulin administration (injections or pump)
- Blood glucose monitoring
- Carbohydrate counting
- Regular physical activity
- Medical follow-up

**Challenges:**
- Daily disease management responsibilities
- Risk for acute complications (hypoglycemia, diabetic ketoacidosis)
- Long-term complications (retinopathy, nephropathy, neuropathy, cardiovascular disease)
- Psychosocial burden
- Transition to adult care

### Diabetes (Type 2)

**Definition:** Disorder where body doesn't properly use insulin or doesn't make enough insulin.

**Prevalence:** 20.5% of adults aged 65+; increasing in youth parallel to obesity trends.

**Risk Factors:** Obesity, family history, certain ethnicities, sedentary lifestyle, age.

**Complications:** Cardiovascular disease, neuropathy, nephropathy, retinopathy, increased infection risk, poor wound healing.

**Prevention/Treatment:** Healthy eating, physical activity, weight management, medications (metformin, insulin when needed), blood glucose monitoring.

### Disenfranchised Grief

**Definition:** Grief not socially recognized or validated.

**Examples:**
- Death due to AIDS
- Suicide of loved one
- Perinatal deaths
- Abortions
- Death of pet, lover, or ex-spouse
- Psychological losses (partner developing Alzheimer's)

**Impact:** Intensified symptoms due to lack of social support and formal mourning practices.

### Emphysema

**Definition:** Lung condition where air sacs are damaged, making breathing difficult.

**Prevalence:** 4.0% of adults aged 65+.

**Cause:** Primarily smoking; can be part of COPD.

**Symptoms:** Progressive shortness of breath, chronic cough, wheezing, chest tightness.

**Treatment:** No cure; bronchodilators, corticosteroids, oxygen therapy, pulmonary rehabilitation, smoking cessation. Some may benefit from surgery.

### Erectile Dysfunction (ED)

**Definition:** Inability to achieve or maintain erection sufficient for sexual activity.

**Causes in Older Adults:**
- Chronic illnesses (diabetes, heart disease)
- Medications
- Hormonal changes
- Psychological factors
- Vascular problems

**Prevalence:** Most men experience occasionally; increases with age and health problems.

**Impact:** Can affect self-esteem, relationships, quality of life. Decline in sexual activity for heterosexual older couples often due to male's physical health.

**Treatment:** Medications (PDE5 inhibitors), lifestyle modifications, addressing underlying health conditions, psychological counseling.

### Familial Alzheimer's Disease

**Definition:** Alzheimer's caused by inheritance of deterministic genes.

**Characteristics:**
- Early onset (symptoms in 30s, 40s, 50s)
- Accounts for 5% of Alzheimer's cases
- Rare genes directly cause the disease
- Strong family history

**Genes Involved:** Several rare genes identified that directly cause early-onset Alzheimer's.

### Fatty Liver Disease

**Definition:** Accumulation of fat in liver exceeding 5% of liver weight.

**Prevalence:** Present in 33% of American adults.

**Causes:**
- Historical: Excessive alcohol consumption
- Current primary causes: Increased caloric intake, obesity, physical inactivity

**Severity:** Mild to moderate levels can be reversed through healthy lifestyle changes.

**Complications:** Can progress to cirrhosis and liver failure if not addressed.

**Treatment:** Healthy diet, weight loss, increased physical activity, limiting alcohol.

### Generalized Anxiety Disorder (GAD)

**Definition:** Excessive anxiety and worry about multiple events or activities.

**DSM-5 Criteria:**
- Excessive anxiety/worry more days than not for at least 6 months
- Difficult to control worry
- Associated with physical symptoms: restlessness, fatigue, difficulty concentrating, irritability, muscle tension, sleep disturbance

**Treatment:**
- Cognitive-Behavioral Therapy
- Medications (SSRIs, SNRIs, benzodiazepines for short-term)
- Relaxation techniques
- Lifestyle modifications (exercise, sleep, stress management)

### Glaucoma

**Definition:** Loss of peripheral vision due to buildup of fluid in eye damaging optic nerve.

**Progression:** As disease advances, more peripheral visual field deteriorates toward central vision. Advanced stages can cause blindness.

**Risk Factors:** Age over 60, diabetes, family history of glaucoma.

**Treatment:** No cure, but progression can be slowed with early diagnosis. Treatments include eye drops, medications, laser treatment, surgery.

### Gonorrhea

**Definition:** Bacterial sexually transmitted infection.

**Prevalence:** 350,000 cases in 2014.

**Symptoms:** Can be asymptomatic. When present: discharge, burning during urination, rectal/throat symptoms.

**Complications:** PID, infertility, disseminated infection if untreated. Increasing antibiotic resistance makes treatment more challenging.

**Treatment:** Antibiotics (though resistance increasing).

### Heart Disease

**Definition:** Various conditions affecting the heart, most commonly atherosclerosis.

**Prevalence:** 17.9% of adults aged 65+; leading cause of death in late adulthood.

**Changes with Age:**
- Heart muscles thicken
- Arteries become less flexible
- Not part of normal aging but disease-related

**Risk Factors:** Hypertension, high cholesterol, smoking, diabetes, obesity, physical inactivity, family history, age.

**Treatment:** Medications (blood pressure, cholesterol, antiplatelet), lifestyle modifications, surgical interventions (angioplasty, bypass surgery), cardiac rehabilitation.

### Hepatitis B

**Definition:** Viral infection affecting the liver.

**Transmission:** Sexually, through blood exposure, mother-to-child.

**Vaccine:** Available; recommended for all infants and unvaccinated adults at risk.

**Complications:** Can become chronic, leading to liver damage, cirrhosis, liver cancer.

**Treatment:** Antiviral medications for chronic cases; supportive care for acute cases.

### Herpes Simplex Virus (HSV-1 and HSV-2)

**Definition:** Viral sexually transmitted infection causing genital herpes.

**Characteristics:**
- Painful blisters or sores
- Incurable but manageable
- Can be transmitted even without visible symptoms
- HSV-1 traditionally oral, HSV-2 traditionally genital (though either can infect either site)

**Treatment:** Antiviral medications reduce outbreak frequency and severity.

### HIV (Human Immunodeficiency Virus)

**Definition:** Virus that attacks immune system, potentially leading to AIDS.

**Transmission:** Sexual contact, blood exposure, sharing needles, mother-to-child.

**Prevalence:** Nearly 25% of people living with HIV-AIDS in US are 50 or older.

**Treatment:** Antiretroviral therapy (ART) can suppress virus to undetectable levels, preventing AIDS and transmission. Without treatment, progressively destroys immune function.

**Testing:** Only 25% of adults 50+ who were single or had new partner used condom during last sex; 40% have never been tested for HIV.

### Human Papillomavirus (HPV)

**Definition:** Most common sexually transmitted infection.

**Types:**
- Some cause genital warts
- Others cause cervical, anal, throat, and other cancers

**Prevalence:** Most sexually active people will get HPV at some point; immune system usually clears infection.

**Vaccine:** Available; prevents most dangerous cancer-causing types. Recommended for all children at age 11-12, catch-up through age 26.

**Treatment:** No cure for virus; treatments available for warts and precancerous changes.

### Hypertension (High Blood Pressure)

**Definition:** Persistently elevated blood pressure.

**Prevalence:** 56.7% of adults aged 65+.

**Risks:** Stroke, heart disease, kidney disease, cognitive decline.

**Treatment:** Lifestyle modifications (diet, exercise, weight loss, sodium reduction), medications (ACE inhibitors, ARBs, diuretics, beta-blockers, calcium channel blockers).

### Insomnia

**Definition:** Difficulty falling asleep, staying asleep, or early morning awakening with inability to return to sleep.

**Prevalence:** Approximately 24% of Americans; most common sleep problem in those 60+.

**Causes:** Stress, medications, pain, medical/psychiatric conditions, poor sleep hygiene, worry about sleep.

**Consequences:**
- Daytime fatigue/sleepiness
- Difficulty concentrating, memory problems
- Mood disturbances (irritability, depression, anxiety)
- Reduced work/school performance
- Increased accident risk
- Weakened immune function
- Increased risk for chronic health conditions

**Treatment:**
- Cognitive-Behavioral Therapy for Insomnia (CBT-I) - most effective long-term
- Sleep hygiene improvements
- Relaxation techniques
- Medications (short-term use)
- Addressing underlying causes

### Kidney Disease

**Definition:** Kidneys become less efficient in removing waste from blood with age.

**Prevalence:** 5.1% of adults aged 65+.

**Causes:** Diabetes, hypertension, glomerulonephritis, polycystic kidney disease, prolonged obstruction, recurrent kidney infection.

**Symptoms:** Often asymptomatic in early stages; later stages show fatigue, swelling, changes in urination, poor appetite.

**Treatment:** Managing underlying conditions, dietary modifications, medications, dialysis or transplant in end-stage disease.

### Kyphosis

**Definition:** Forward curvature of spine resulting in hunched posture.

**Cause:** Weakened bones in spine, often from osteoporosis.

**Progression:** Gradual loss of height and increasing curvature.

**Impact:** Can make walking or sitting up difficult over time.

**Prevention/Treatment:** Preventing bone loss through calcium, vitamin D, exercise; physical therapy; bracing; surgery in severe cases.

### Lewy Body Disease (Neurocognitive Disorder with Lewy Bodies)

**Definition:** Neurocognitive disorder caused by abnormal protein deposits (Lewy bodies) in neurons.

**Prevalence:** Third most common neurocognitive disorder; affects over 1 million Americans.

**Onset:** Typically age 50 or older.

**Duration:** 5-7 years from diagnosis to death (range 2-20 years).

**Pathology:** Lewy bodies affect brain chemicals impacting thinking, movement, behavior, and mood.

**Symptoms:**
- Cognitive symptoms (fluctuating confusion, attention problems)
- Motor symptoms similar to Parkinson's (tremors, rigidity) occurring simultaneously with cognitive symptoms
- Visual hallucinations
- Sleep disturbances
- Falls

**Diagnosis:** Only confirmed via autopsy.

**Demographics:** Slightly more men than women affected.

**Treatment:** Symptomatic management; no cure.

### Macular Degeneration (Age-Related)

**Definition:** Loss of clarity in center field of vision due to deterioration of macula (center of retina).

**Types:**
- **Dry:** Fatty protein pieces (drusen) form beneath retina, thinning macula
- **Wet:** Abnormal blood vessel development beneath retina, may leak fluid/blood causing rapid vision loss

**Impact:** Can greatly impair day-to-day functioning.

**Risk Factors:** Smoking, race, high cholesterol, family history.

**Treatment:**
- Dry type: Certain antioxidant vitamins/minerals may slow progression
- Wet type: Medications slowing abnormal blood vessel growth, laser treatment

### Major Neurocognitive Disorder

**Definition (DSM-5):** Significant cognitive decline from previous level of performance in one or more cognitive domains that interferes with independent functioning.

**Common Types:**
- Alzheimer's disease (most common)
- Vascular neurocognitive disorder
- Neurocognitive disorder with Lewy bodies
- Frontotemporal neurocognitive disorder
- Parkinson's disease-related

**Diagnosis:** Medical history, physical exam, laboratory tests, observation of behavioral changes.

### Minor Neurocognitive Disorder

**Definition (DSM-5):** Modest cognitive decline from previous level of performance in one or more cognitive domains that does NOT interfere with independent functioning.

**Distinction from Major:** Level of impairment; minor allows continued independence in daily activities.

### Narcolepsy

**Definition:** Neurological disorder causing excessive daytime sleepiness and sudden sleep attacks.

**Additional Symptoms:** Cataplexy (sudden muscle weakness triggered by emotions), sleep paralysis, hypnagogic hallucinations.

**Treatment:** Stimulant medications, scheduled naps, consistent sleep schedule, avoiding triggers.

### Obesity

**Definition:** Excessive body fat accumulation presenting health risks.

**Measurement:** BMI ≥30 for adults; ≥95th percentile for age/sex in children.

**Prevalence:**
- Adults: 39.8% classified as obese
- Children/Adolescents: 20.5% obese in 2014 (vs 5% in 1980)

**Causes:**
- Genetic factors (energy-thrifty genes)
- Environmental factors (obesogenic environment)
- Behavioral factors (poor dietary choices, physical inactivity)
- Metabolic changes (slowing metabolism with age)
- Psychological factors (stress, emotional eating)

**Health Consequences:**
- Increased mortality risk
- Cardiovascular disease
- Type 2 diabetes, metabolic syndrome
- Musculoskeletal problems (osteoarthritis)
- Respiratory issues (sleep apnea)
- Cancer (multiple types)
- Mental health problems (depression, anxiety, low self-esteem)
- Other: Gallbladder disease, fatty liver, pregnancy complications

**Medical Costs:** $147 billion in 2008.

**Treatment:**
- Dietary interventions
- Physical activity
- Behavioral therapy
- Pharmacological treatment (BMI ≥30 or ≥27 with complications)
- Bariatric surgery (BMI ≥40 or ≥35 with serious complications)
- Comprehensive programs most effective

### Obsessive-Compulsive Disorder (OCD)

**Definition:** Disorder characterized by obsessions (intrusive thoughts) and/or compulsions (repetitive behaviors).

**Symptoms:**
- Obsessions: Recurrent unwanted thoughts, urges, or images causing anxiety
- Compulsions: Repetitive behaviors or mental acts performed to reduce anxiety
- Time-consuming, cause significant distress or impairment

**Treatment:**
- Cognitive-Behavioral Therapy (particularly exposure and response prevention)
- Medications (SSRIs, clomipramine)
- Combination of therapy and medication often most effective

### Osteoarthritis

**Definition:** Wear and tear on joints causing cartilage and bone breakdown.

**Prevalence:** Most common type of arthritis; 48.7% of adults aged 65+.

**Risk Factors:** Genetics, obesity, age, previous injury, other medical conditions.

**Symptoms:** Joint pain, stiffness, swelling, reduced range of motion, difficulty moving.

**Impact:** Most common cause of disability; affects mobility, increases depression/anxiety risk.

**Treatment:** Pain management, physical therapy, exercise, weight management, assistive devices, joint replacement surgery when severe.

### Osteoporosis

**Definition:** Disease that thins and weakens bones making them fragile and prone to fractures.

**Prevalence:** After age 50, 1 in 2 women and 1 in 4 men will experience osteoporosis-related fracture.

**Common Fractures:** Hip, spine, wrist.

**Impact:** Hip fractures greatly increase death risk, especially in year following fracture.

**Complications:** Can lead to kyphosis (hunched posture) from spinal compression fractures.

**Prevention:**
- Adequate calcium and vitamin D
- Regular weight-bearing exercise
- Limiting alcohol
- Not smoking

**Treatment:** Medications to slow bone loss or promote bone formation, fall prevention strategies.

### Panic Disorder

**Definition:** Recurrent unexpected panic attacks with persistent concern about future attacks.

**Panic Attack Symptoms:**
- Sudden surge of intense fear/discomfort
- Palpitations, sweating, trembling
- Shortness of breath, chest pain
- Nausea, dizziness
- Fear of losing control or dying
- Peaks within minutes

**Treatment:**
- Cognitive-Behavioral Therapy
- Medications (SSRIs, SNRIs, benzodiazepines)
- Breathing techniques, relaxation training

### Parkinson's Disease

**Definition:** Neurodegenerative disorder characterized by motor symptoms.

**Symptoms:**
- Motor tremors
- Loss of balance
- Poor coordination
- Rigidity
- Difficulty moving

**Prevalence:** Approximately 1% of those over age 60; hereditary in less than 10% of cases.

**Causes:**
- 28 chromosomal areas implicated
- Environmental factors: Brain injury, toxins, industrial chemicals, carbon monoxide, herbicides, pesticides
- Brain injury increases risk (knocked unconscious once: +32%; multiple times: +174%)

**Pathophysiology:** Deterioration of midbrain area sending dopamine to basal ganglia, affecting motor activity.

**Treatment:**
- Levodopa (L-dopa) medication
- Deep brain stimulation (electrical stimulation improving motor function)
- Symptomatic management

**Sleep Issues:** Commonly causes sleep problems.

### Pelvic Inflammatory Disease (PID)

**Definition:** Infection of female reproductive organs.

**Causes:** Often from untreated STIs (chlamydia, gonorrhea).

**Symptoms:** Pelvic pain, abnormal discharge, fever, painful intercourse/urination.

**Complications:** Infertility, ectopic pregnancy, chronic pelvic pain, abscess formation.

**Treatment:** Antibiotics; partner treatment necessary to prevent reinfection.

### Periodic Limb Movement Disorder

**Definition:** Involuntary jerking and kicking of legs during sleep.

**Frequency:** Movements occur every 20-40 seconds.

**Impact:** Disrupts sleep quality.

**Prevalence:** More common in older adults.

**Treatment:** Medications (dopamine agonists, benzodiazepines), treating underlying conditions.

### Post-Traumatic Stress Disorder (PTSD)

**Definition:** Disorder developing after exposure to traumatic events.

**Symptoms:**
- Intrusive memories, nightmares, flashbacks
- Avoidance of trauma-related stimuli
- Negative alterations in cognition and mood
- Hyperarousal (irritability, hypervigilance, exaggerated startle response)

**Treatment:**
- Cognitive-Behavioral Therapy (particularly trauma-focused CBT)
- EMDR (Eye Movement Desensitization and Reprocessing)
- Medications (SSRIs, SNRIs)
- Group therapy

### Presbycusis

**Definition:** Age-related gradual hearing loss.

**Characteristics:**
- Runs in families
- Results in gradual hearing loss
- Affects hearing in both ears

**Prevalence:** Incidence increases with age; males have higher rates worldwide.

**Impact:** Difficulty hearing high frequencies, understanding speech in noisy environments.

**Treatment:** Hearing aids, assistive listening devices, communication strategies.

### Presbyosmia

**Definition:** Age-related loss of smell.

**Onset:** Problems begin after age 50; evident changes noticed by age 60.

**Prevalence:** More common in men than women.

**Concerns:** May be linked to serious medical conditions (Parkinson's, Alzheimer's, multiple sclerosis). Sudden changes should be evaluated.

**Impact:** Affects taste perception, food enjoyment, safety (detecting gas leaks, spoiled food).

### Presbyopia

**Definition:** Age-related loss of ability to focus on close objects.

**Cause:** Lens of eye becomes less flexible with age.

**Symptoms:** Difficulty reading small print, need to hold reading material farther away, eyestrain, headaches.

**Treatment:** Reading glasses, bifocals, progressive lenses, contact lenses.

### Rapid Eye Movement Sleep Behavior Disorder

**Definition:** Sleep disorder where muscles can move during REM sleep, disrupting sleep.

**Symptoms:** Acting out dreams, potentially violent movements, vocalizations during sleep.

**Risks:** Injury to self or bed partner.

**Prevalence:** More common in older adults; associated with neurodegenerative disorders.

**Treatment:** Medications (melatonin, clonazepam), safety measures (padding bed, sleeping alone).

### Restless Legs Syndrome

**Definition:** Uncomfortable sensations in legs creating urge to move them.

**Symptoms:** Tingling, crawling, pins-and-needles sensations; worse at night and with inactivity.

**Impact:** Difficulty falling asleep, frequent awakenings, daytime fatigue.

**Treatment:** Medications (dopamine agonists, gabapentin), lifestyle changes (avoiding triggers), treating underlying conditions.

### Rheumatoid Arthritis (RA)

**Definition:** Inflammatory autoimmune disease attacking joint membrane linings.

**Characteristics:**
- Symmetric attack on body (if one side affected, so is other)
- Affects multiple organ systems
- Not normal wear and tear (unlike osteoarthritis)

**Symptoms:**
- Tender, warm, swollen joints
- Symmetric pattern of affected joints
- Often affects wrists, fingers, but can affect neck, shoulders, elbows, hips, knees, ankles, feet
- Fatigue, occasional fevers, loss of energy
- Morning stiffness lasting >30 minutes
- Symptoms last for years with variability

**Prevalence:** Approximately 1.5 million Americans (0.6%); more common in middle adulthood and increases with age; 2-3 times more common in women.

**Lifetime Risk:** Women 3.6%; men 1.7%.

**Causes:**
- Genetic factors (individual genes confer small risk)
- Environmental triggers
- Possible hormonal factors (improves during pregnancy, flares after; oral contraceptives may increase risk)

**Impact:**
- Can affect all areas of life
- Interferes with work and family responsibilities
- 62% of adults with arthritis aged 65+ have some mobility limitations

**Treatment:**
- Pain-relieving drugs
- Disease-modifying antirheumatic drugs (DMARDs)
- Biologics
- Physical therapy
- Balance between rest and exercise

### Schizophrenia

**Definition:** Serious mental illness affecting thinking, feeling, and behavior.

**Symptom Categories:**

**Positive Symptoms** (additions to normal functioning):
- Hallucinations (false perceptions, often auditory)
- Delusions (false beliefs)
- Disorganized thinking and speech
- Grossly disorganized or catatonic behavior

**Negative Symptoms** (diminutions of normal functioning):
- Reduced emotional expression (flat affect)
- Avolition (decreased motivation)
- Anhedonia (inability to experience pleasure)
- Social withdrawal
- Poverty of speech (alogia)

**Cognitive Symptoms:**
- Impaired working memory
- Difficulty with attention and concentration
- Executive function deficits

**Onset:** Late adolescence or early adulthood (late teens to mid-twenties for men, mid-twenties to early thirties for women).

**Course:** Typically chronic with periods of acute symptoms and partial remission.

**Treatment:**
- Antipsychotic medications (reduce positive symptoms)
- Psychosocial interventions (CBT, family therapy, social skills training, supported employment)
- Coordinated Specialty Care for first-episode psychosis
- Long-term management necessary

### Shingles (Herpes Zoster)

**Definition:** Disease affecting nerves caused by reactivation of varicella-zoster virus (VZV).

**Cause:** Same virus as chickenpox; virus remains dormant in nerve cells after chickenpox recovery.

**Risk Factors:**
- Advanced age (half of cases in adults 60+; increases by age 70)
- Weakened immune system (cancer, HIV, medical conditions)

**Symptoms:**
- Pain, burning, tingling, or itching in affected area
- Rash and blisters typically on one side of body or face in small area
- Post-herpetic neuralgia (PHN) - ongoing pain after rash resolves

**Complications:**
- PHN can interfere with daily activities, cause depression, anxiety, sleeplessness
- Infected blisters or scarring
- Eye damage or blindness (if near eyes)
- Brief facial paralysis
- Hearing loss
- Rarely: Encephalitis (brain swelling)

**Treatment:** Antiviral medications (most effective when started within 72 hours of rash onset), pain management, symptomatic relief.

**Prevention:** Shingles vaccine recommended for adults 50+.

### Sleep Apnea

**Definition:** Repeated interruptions in breathing during sleep.

**Types:**
- **Obstructive Sleep Apnea:** Airway obstruction
- **Central Sleep Apnea:** Brain signal problems

**Symptoms:**
- Loud snoring
- Gasping or choking during sleep
- Excessive daytime sleepiness
- Morning headaches
- Difficulty concentrating
- Irritability

**Prevalence:** 71% of diagnosed sleep disorder cases; 9% of Americans diagnosed with sleep disorder.

**Risk Factors:** Obesity, age, male gender, anatomical features, family history.

**Health Consequences:**
- Hypertension
- Heart disease and heart failure
- Stroke
- Type 2 diabetes
- Cognitive impairment
- Increased mortality risk

**Treatment:**
- Continuous Positive Airway Pressure (CPAP) - most effective
- Weight loss (if overweight)
- Positional therapy (avoiding back sleep)
- Oral appliances
- Surgery (severe cases or anatomical abnormalities)

### Social Anxiety Disorder

**Definition:** Marked fear or anxiety about social situations involving potential scrutiny.

**Symptoms:**
- Fear of negative evaluation by others
- Fear of acting in embarrassing ways
- Avoidance of social situations or enduring them with intense distress
- Physical symptoms (blushing, sweating, trembling, nausea)

**Treatment:**
- Cognitive-Behavioral Therapy (particularly exposure therapy)
- Medications (SSRIs, SNRIs)
- Social skills training

### Specific Phobia

**Definition:** Marked fear or anxiety about specific objects or situations.

**Common Phobias:** Flying, heights, animals, blood, enclosed spaces.

**Characteristics:**
- Fear out of proportion to actual danger
- Leads to avoidance
- Causes significant distress or impairment

**Treatment:**
- Exposure therapy (most effective)
- Cognitive-Behavioral Therapy
- Medications (benzodiazepines for short-term use, beta-blockers for performance situations)

### Stroke

**Definition:** Interruption of blood flow to brain causing cell death.

**Prevalence:** 7.2% of adults aged 65+.

**Types:**
- Ischemic: Blood clot blocks artery
- Hemorrhagic: Blood vessel ruptures

**Risk Factors:** Hypertension, diabetes, smoking, atrial fibrillation, high cholesterol, obesity, excessive alcohol.

**Symptoms:** Sudden numbness/weakness (especially one-sided), confusion, trouble speaking/understanding, vision problems, dizziness, loss of balance, severe headache.

**Treatment:** Emergency intervention (clot-busting drugs for ischemic stroke), rehabilitation, addressing risk factors.

**Complications:** Can cause paralysis, aphasia, cognitive impairment, emotional changes.

### Substance Use Disorders

**Definition:** Problematic patterns of substance use leading to clinically significant impairment or distress.

**Common Substances:**
- Alcohol
- Tobacco/nicotine
- Marijuana
- Prescription medications (opioids, benzodiazepines, stimulants)
- Cocaine
- Methamphetamine
- Heroin

**Risk Factors:**
- Genetic (40-60% of vulnerability)
- Environmental (peer influence, access, family dysfunction, trauma)
- Psychological (mental health disorders, poor stress management, low self-esteem)
- Developmental (adolescent brain vulnerability)

**Treatment:**
- Detoxification
- Medication-Assisted Treatment (MAT)
- Behavioral therapies (CBT, motivational interviewing, contingency management)
- Residential treatment
- Outpatient programs
- Support groups (12-step, SMART Recovery)
- Recovery support services

**Nature:** Chronic conditions often requiring long-term treatment and multiple episodes of care.

### Syphilis

**Definition:** Bacterial sexually transmitted infection progressing through stages.

**Prevalence:** 20,000 cases in 2014.

**Stages:**
- Primary: Painless chancre (sore) at infection site
- Secondary: Rash, flu-like symptoms
- Latent: No symptoms
- Tertiary: Affects multiple organs including brain and heart if untreated

**Treatment:** Treatable with antibiotics, particularly in early stages. Later stages may have permanent damage.

### Tinnitus

**Definition:** Ringing, hissing, or roaring sound in ears.

**Causes:** Unknown exact cause; related to hypertension, allergies, age-related changes, noise exposure.

**Prevalence:** Incidence increases with age; males have higher rates worldwide.

**Impact:** Can interfere with hearing, concentration, sleep, quality of life.

**Treatment:** Addressing underlying causes, sound therapy, cognitive-behavioral therapy, hearing aids, medications for associated conditions.

### Trichomoniasis

**Definition:** Parasitic sexually transmitted infection.

**Symptoms:** Often asymptomatic, particularly in men. Women may experience discharge, itching, burning, redness.

**Treatment:** Curable with antibiotics.

### Type 1 Diabetes

See **Diabetes (Type 1)**

### Type 2 Diabetes

See **Diabetes (Type 2)**

### Ulcers

**Definition:** Sores in stomach or intestinal lining.

**Prevalence:** 11.3% of adults aged 65+.

**Causes:** H. pylori bacteria, long-term NSAID use, excessive acid production, stress (contributory).

**Symptoms:** Burning stomach pain, bloating, heartburn, nausea, intolerance to fatty foods.

**Treatment:** Antibiotics (if H. pylori), acid-reducing medications, avoiding irritants.

### Vascular Neurocognitive Disorder

**Definition:** Second most common neurocognitive disorder caused by blockage of cerebral blood vessels.

**Prevalence:** 0.2% in 65-70 age group; 16% of those 80+.

**Characteristics:**
- Affects one part of brain rather than general loss (unlike Alzheimer's)
- Personality less affected
- More males diagnosed than females
- More abrupt onset than Alzheimer's
- Shorter course before death

**Risk Factors:** Smoking, diabetes, heart disease, hypertension, history of strokes.

**Treatment:** Managing risk factors, preventing further strokes, symptomatic management.

### Widowhood Mortality Effect

**Definition:** Higher risk of death following death of spouse.

**Findings:**
- Widowhood increases risk of dying from almost all causes
- Risk lower if time to prepare (terminal illness)
- Men show higher risk if they have health problems
- Widowers have higher suicide risk than widows

**Mechanisms:** Stress of loss, lifestyle changes, reduced self-care, loneliness, grief.

## Non-Suicidal Self-Injury (NSSI)

**Definition:** Deliberately harming oneself without intent to die.

**Common Forms:** Cutting (most common), burning, scratching, hitting.

**Onset:** Typically begins in early-to-mid adolescence.

**Functions:**
- Emotion regulation (reducing intense negative emotions or numbness)
- Self-punishment
- Communication (expressing distress to others)
- Sensation-seeking

**Risk:** Increases suicide risk despite being non-suicidal behavior.

**Treatment:** 
- Psychotherapy (DBT particularly effective for emotion regulation skills)
- Addressing underlying mental health conditions
- Teaching alternative coping strategies
- Safety planning

## Opioid Use Disorder and Overdose Epidemic

**Definition:** Problematic pattern of opioid use causing significant impairment or distress.

**Substances Involved:**
- Prescription pain medications (oxycodone, hydrocodone, morphine)
- Synthetic opioids (fentanyl)
- Heroin

**Prevalence:** In 2016, 3.6% of 12-17-year-olds and twice as many 18-25-year-olds reported opioid misuse.

**Consequences:** In 2014, more than 1,700 emerging adults died from prescription drug overdoses (fourfold increase since 1999). For every death, 119 additional emergency room visits.

**Overdose Risk:** Opioids depress respiratory function; overdoses can be fatal. Fentanyl (50-100 times more potent than morphine) in illicit drug supply has dramatically increased deaths.

**Progression:** Often begins with legitimate prescriptions for pain, escalates to dependence and addiction, may transition to heroin as cheaper alternative.

**Treatment:**
- Medication-Assisted Treatment (methadone, buprenorphine, naltrexone)
- Behavioral therapy
- Naloxone (reversal of overdose)
- Comprehensive addiction treatment programs

## Suicide and Suicidal Behavior

**Definition:** Death caused by self-directed injurious behavior with intent to die.

**Prevalence:** Leading cause of death among adolescents and young adults (among top three causes). Rates increasing across age groups.

**Risk Factors:**

**Mental Health:**
- Depression, anxiety, bipolar disorder, schizophrenia
- Substance use disorders
- PTSD and trauma-related conditions
- Previous suicide attempts (strongest predictor)
- Non-suicidal self-injury

**Psychosocial:**
- Relationship problems or loss
- Social isolation and loneliness
- Bullying or victimization
- Academic or occupational stress
- Financial problems
- Legal difficulties

**Demographic:**
- Males have higher completion rates; females have higher attempt rates
- LGBTQ+ individuals face elevated risk (especially with family rejection/discrimination)
- Some ethnic minority groups show elevated rates
- Access to lethal means (firearms, medications)

**Developmental:**
- Impulsivity (particularly adolescents)
- Hopelessness about future
- Recent psychiatric hospitalization or discharge
- Chronic illness or pain

**Warning Signs:**
- Talking about wanting to die or kill oneself
- Looking for methods
- Talking about hopelessness or lack of purpose
- Talking about feeling trapped or unbearable pain
- Increased substance use
- Acting anxious or agitated
- Withdrawing from others
- Changing eating or sleeping patterns
- Showing rage or seeking revenge
- Taking risks that could lead to death
- Giving away possessions
- Saying goodbye
- Putting affairs in order
- Sudden mood improvement after depression (may indicate decision to attempt)

**Prevention:**
- Mental health treatment
- Safety planning and means restriction
- Skills training (emotion regulation, problem-solving, distress tolerance)
- Gatekeeper training
- Social support
- Reducing stigma
- Crisis hotlines (988 National Suicide Prevention Lifeline)
- School-based programs
- Responsible media reporting
- Policy interventions

**Intervention:**
- Take seriously; don't leave person alone
- Remove access to lethal means
- Contact crisis services (988, emergency services)
- Transport to emergency department if necessary
- Stay until professional help engaged

**Postvention:** Support for survivors of suicide loss; grief support, reducing contagion, connecting to resources.

## Conclusion

This comprehensive summary encompasses the wide range of pathologies, disorders, and medical conditions discussed throughout the Human Growth and Development textbook. Understanding these conditions within a developmental framework helps illuminate how biological, psychological, and social factors interact to influence health across the lifespan. From genetic conditions present at birth to age-related degenerative diseases, from acute infections to chronic illnesses, and from temporary developmental challenges to lifelong conditions, this reference demonstrates the complexity of human health and development.

Early identification, evidence-based treatment, and comprehensive support addressing medical, psychological, and social needs are essential for optimal outcomes across all conditions. Many disorders benefit from multidisciplinary approaches involving medical professionals, mental health providers, educators, families, and community resources working together. Prevention through health promotion, risk reduction, and early intervention remains crucial for reducing disease burden and improving quality of life throughout the lifespan.

The integration of this pathology knowledge with understanding of typical development enables professionals, students, and caregivers to better support individuals facing health challenges at any age, recognizing both the unique aspects of each condition and the common human experiences of adaptation, resilience, and growth in the face of adversity.

## Key Terms

All key terms for specific pathologies are listed in their respective sections above. Additional general terms relevant to pathology and health:

- **Acute:** Condition with rapid onset and short duration
- **Chronic:** Condition that is ongoing and long-lasting
- **Comorbidity:** Presence of two or more disorders/conditions in the same person
- **Congenital:** Present from birth
- **Degenerative:** Progressively worsening condition
- **Diagnostic criteria:** Specific symptoms and characteristics required for diagnosis
- **Etiology:** Cause or origin of a disease
- **Hereditary:** Passed from parent to child through genes
- **Idiopathic:** Of unknown cause
- **Incidence:** Number of new cases within a specific time period
- **Morbidity:** State of being diseased or unhealthy
- **Mortality:** Death rate
- **Pathology:** Study of disease; abnormal condition
- **Prevalence:** Total number of cases (both new and existing) at a given time
- **Prognosis:** Expected course and outcome of a disease
- **Remission:** Reduction or disappearance of signs and symptoms
- **Risk factor:** Characteristic increasing likelihood of developing a condition
- **Symptom:** Subjective indication of disease experienced by patient
- **Syndrome:** Group of symptoms occurring together characterizing a condition
